XML 69 R55.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Business Segment Information - Summary of EBIDTA by Reporting Segment (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Segment Reporting Information [Line Items]    
Consolidated adjusted EBITDA $ 7,665 $ 3,204
Interest expense, net 4,558 1,289
Depreciation and amortization 14,862 12,670
Share-based compensation expense 8,800 13,020
Foreign exchange impact 1,588 (583)
SeaSpine merger-related costs 4,520 20,740
Strategic investments 120 661
Acquisition-related fair value adjustments 4,217 11,636
Interest and loss on investments (260)  
Litigation and investigation costs 2,260 469
Succession charges 2,210  
Medical device regulation   3,629
All other (41)  
Loss before income taxes (35,169) (60,327)
Operating Segments [Member] | Global Spine [Member]    
Segment Reporting Information [Line Items]    
Consolidated adjusted EBITDA 19,890 14,981
Operating Segments [Member] | Global Orthopedics [Member]    
Segment Reporting Information [Line Items]    
Consolidated adjusted EBITDA (1,492) 44
Corporate, Non-Segment [Member]    
Segment Reporting Information [Line Items]    
Consolidated adjusted EBITDA $ (10,733) $ (11,821)